Refine results:

Clear all

Vaccines on a conveyor belt

Opinion | 20 November 2020

Four reasons why we need multiple vaccines for Covid-19 by Charlie Weller

Having a range of Covid-19 vaccines available for people to use around the world will be essential to bringing the pandemic under control. Here’s why.

Hand holding a vaccine next to a sequence of messenger RNA genetic code

Explainer | 19 November 2020

Seven vital questions about the RNA Covid-19 vaccines emerging from clinical trials

Preliminary data from phase III clinical trials has shown the Pfizer-BioNTech and Moderna Covid-19 vaccines to be more than 90% effective. So, how do they work, are they safe, and when will they be available? 

Two researchers at the Wellcome Centre for Human Genetics in Oxford.

Opinion | 20 October 2020

Wellcome's bold ambitions to improve health through our new strategy by Jeremy Farrar

We've introduced a new vision and strategy for Wellcome that we hope will have significant positive impacts on the course of human health over the next two decades.

An intensive care nurse attends to a patient that is being treated for COVID-19 at a hospital.

Explainer | 19 October 2020

We need Covid-19 treatments as well as vaccines – and they have to work for everyone

Effective treatments, that are accessible to everyone who needs them, have to be part of the solution to the coronavirus pandemic – here's why.

Animation showing a doctor administering a vaccine to a volunteer

Explainer | 25 September 2020

What are human infection studies and why do we need them?

Human infection studies have the power to rapidly accelerate the development of much-needed vaccines and treatments, including for Covid-19.

A woman walks inside a clinical trials centre, in front of a sign which reads Covid-19 vaccine trials here

Explainer | 11 September 2020

Safety first: how to run a Covid-19 vaccine clinical trial

The world is waiting eagerly for Covid-19 vaccines to be developed as quickly as possible. But to make sure they are safe and effective, the clinical trials that test them have to be robust. So how do trials achieve this?

A nurse wearing a face mask and a vaccine trial volunteer sitting in an observation room in a repurposed convention centre in Manama, Bahrain.

Opinion | 7 September 2020

The first Covid-19 vaccine may not be the magic bullet that returns life to 'normal' by Jeremy Farrar

As we'll soon start to see the results of the first vaccines coming through late-stage clinical trials, Jeremy Farrar explains why we should be cautiously optimistic.

A kid selling face masks in the street and a health worker wearing a hazmat suit.

Opinion | 20 July 2020

ACT now, ACT together to end COVID-19 by Will Hall

As global efforts continue to make sure COVID-19 tests, treatments and vaccines are available to those who need them the most, Will Hall writes about the importance of a coordinated global response, delivered locally.

People at a street flea market in Italy.

Opinion | 30 June 2020

This virus isn’t going away. The only way to beat it is to work together by Jeremy Farrar

Six months on from the first case of COVID-19, the pandemic is accelerating and spreading into new areas. Jeremy Farrar talks about the lessons we learned and the long-term solutions.

Four health workers carry portable vaccine cold storage boxes

Explainer | 3 June 2020

The vaccine journey: from idea to immunisation

Researchers may well identify a safe, effective vaccine for COVID-19 before too long, but all that fantastic work could count for nothing unless we also invest in the next stages of the vaccine process – manufacturing and delivery.

A girl gets a vaccination against measles from a health worker

Opinion | 1 June 2020

While we wait for a COVID-19 vaccine, let's not forget the importance of the vaccines we already have by Charlie Weller

With measures to prevent the spread of COVID-19 disrupting immunisation around the globe, millions are now at risk of other deadly diseases. We must act and invest urgently to maintain routine immunisation.

A family of three and a worker who goes door to door to screen for COVID-19 in Pretoria, South Africa.

Opinion | 7 May 2020

Coronavirus Global Response helped to raise billions for research. But we need more by Alex Harris

On 4 May, world leaders and health organisations pledged billions for the COVID-19 response. Alex Harris explains that urgent funding gaps remain for research.

Pages